Pharma stocks are in vogue ever since the pandemic hit us last year. Several pharma companies have turned out to be multibaggers in the past couple of years or even in the past one year. 

Sensex is down by more than 2 per cent in one month even as the metal and healthcare-related stocks are buzzing on the bourses.  

Usually, low P/E stocks are considered attractive for investments. However, not all low P/E stocks turn out to be multibaggers. Titan Biotech is one such stock, which is trading at low P/E and is turning out to be a classic multibagger. 

The market opened in red on April 22, 2021.

The market opened in red on April 22, 2021, overall volumes in futures & options currently stand at 4,56,59,667 contracts with a turnover of Rs. 41,71,483.21 crore.

The market opened in red on April 22, 2021, overall volumes in futures & options currently stand at 4,56,59,667 contracts with a turnover of Rs. 41,71,483.21 crore.

Several pharma stocks are rallying and Wanbury is just another lesser-known name that is attracting investors. According to BSE website, the company is trading at a P/E of 4, with a market cap (free float) of Rs 107 crore.  

Hero MotoCorp announced a strategic partnership with Gogoro Inc to accelerate the shift to sustainable electric mobility in India. The partnership aims to bring together Hero and Gogoro, the global leaders in urban battery swapping and smart mobility innovation.

Tata Consultancy Services (TCS), a leading global IT services company announced its partnership with Wavin, Netherlands-based global innovative solutions provider for the building and infrastructure industry to expand in the markets of India & Indonesia. 

Indian markets were seen trading near the day’s high, aided by strong recovery in banking & financial stocks.